Very early remission and increased apoptosis with the use of Pentoxifylline in children with acute lymphoblastic leukemia

Very early remission and increased apoptosis with the use of Pentoxifylline in children with acute lymphoblastic leukemia

IntroductionDespite the improvement in survival in acute lymphoblastic leukemia (ALL), there are still cases with evasion of chemotherapy-induced apoptosis. The IKK/NF-κB signaling pathway contributes to antiapoptotic gene expression. Pentoxifylline (PTX) inhibits IkB phosphorylation, blocking NF-κB...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Violeta Salceda-Rivera, Pablo C. Ortiz-Lazareno, Georgina Hernández-Flores, Jorge R. Vazquez-Urrutia, Jesus Meza-Arroyo, Monzerrat Pardo-Zepeda, Hugo Romo-Rubio, Cesar Barba-Barba, Fernando Sánchez-Zubieta, Carlos Alfredo Barrón-Gallardo, Oscar Gonzalez-Ramella, Alejandro Bravo-Cuellar
التنسيق: مقال
اللغة:English
منشور في: Frontiers Media S.A. 2024-10-01
سلاسل:Frontiers in Oncology
الموضوعات:
MRD
ALL
clinical trials
apoptosis
Pentoxifylline
early remission
الوصول للمادة أونلاين:https://www.frontiersin.org/articles/10.3389/fonc.2024.1401262/full

الانترنت

https://www.frontiersin.org/articles/10.3389/fonc.2024.1401262/full

مواد مشابهة